Session

Focal treatment in prostate cancer

ESU Course 15

  • Location:
    Room 11 (ICM, Level 1)
  • Chair:
     T.E. Bjerklund Johansen, Oslo (NO)
  • Aims and objectives of this session

    Focal treatment is about eradicating the cancer lesion within the prostate while preserving genitourinary function. This interactive course offers delegates
    • understanding of the rationale for focal treatment and patient selection criteria
    • update on principles, outcome and side effects of focal technologies
    • a thorough discussion of biopsy strategies and imaging in diagnostic work-up and follow-up
    • information about existing registries
    As men with prostate cancer are getting younger the side effects of whole gland treatment are getting more important. With several new technologies available a significant development of focal treatment is expected in the coming years.

Welcome and introduction
 T.E. Bjerklund Johansen, Oslo (NO)
Diagnostic work-up
The role of prostate biopsies for ruling in and ruling out prostate cancer in different parts of the gland; The need for biopsy tracking and image fusion systems
 D. Greene, Sunderland (GB)
The role of MRI for ruling in and ruling out prostate cancer in different parts of the gland; The role of N and M-staging by node dissection, PET CT, MRI and bone scan
 J.P.M. Sedelaar, Nijmegen (NL)
Focal treatment methods, outcome and side effects
Cryosurgical ablation
 T.E. Bjerklund Johansen, Oslo (NO)
High intensity focused ultrasound
 D. Greene, Sunderland (GB)
Other technologies
 J.P.M. Sedelaar, Nijmegen (NL)
Follow up after focal therapy
The role of PSA; When to do biopsies
 D. Greene, Sunderland (GB)
The role of MRI; Indications for whole gland treatment; Focal treatment in a salvage setting
 J.P.M. Sedelaar, Nijmegen (NL)
The need for research guidelines and registries (EUCAP; Alpha registry and ECLIPSE)
 T.E. Bjerklund Johansen, Oslo (NO)